The latest price target for Autonomix Medical (NASDAQ:AMIX) was reported by Ladenburg Thalmann on September 3, 2024. The analyst firm set a price target for $1.40 expecting AMIX to fall to within 12 months (a possible -89.06% downside). 1 analyst firms have reported ratings in the last year.

The latest analyst rating for Autonomix Medical (NASDAQ:AMIX) was provided by Ladenburg Thalmann, and Autonomix Medical initiated their buy rating.

There is no last upgrade for Autonomix Medical

There is no last downgrade for Autonomix Medical.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Autonomix Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Autonomix Medical was filed on September 3, 2024 so you should expect the next rating to be made available sometime around September 3, 2025.

While ratings are subjective and will change, the latest Autonomix Medical (AMIX) rating was a initiated with a price target of $0.00 to $1.40. The current price Autonomix Medical (AMIX) is trading at is $12.80, which is out of the analyst’s predicted range.